Back to Journals » Lung Cancer: Targets and Therapy » Volume 9

Lung Cancer: Targets and Therapy


Archive: Volume 9, 2018

Response to rapamycin analogs but not PD-1 inhibitors in PTEN-mutated metastatic non-small-cell lung cancer with high tumor mutational burden

Parikh AR, Ali SM, Schrock AB, Albacker LA, Miller VA, Stephens PJ, Crilley P, Markman M

Lung Cancer: Targets and Therapy 2018, 9:45-47

Published Date: 18 May 2018

Role and inhibition of GLI1 protein in cancer

Mastrangelo E, Milani M

Lung Cancer: Targets and Therapy 2018, 9:35-43

Published Date: 27 March 2018

Uncommon EGFR mutations in cytological specimens of 1,874 newly diagnosed Indonesian lung cancer patients

Syahruddin E, Wulandari L, Sri Muktiati N, Rima A, Soeroso N, Ermayanti S, Levi M, Hidajat H, Widjajahakim G, Utomo ARH

Lung Cancer: Targets and Therapy 2018, 9:25-34

Published Date: 23 March 2018

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer

Veldore VH, Choughule A, Routhu T, Mandloi N, Noronha V, Joshi A, Dutt A, Gupta R, Vedam R, Prabhash K

Lung Cancer: Targets and Therapy 2018, 9:1-11

Published Date: 3 January 2018